Massachusetts General Hospital, Boston, MA
Yael Bar , Gary X. Wang , Gabrielle E. Gioia , Veerle I. Bossuyt , Shirley Shinn-Huey Chou , Steven J. Isakoff , Beverly Moy , Leif W. Ellisen , Constance Dobbins Lehman , Laura Spring
Background: A breast biopsy tissue biobank is a valuable resource for studying breast cancer biology and treatment response. However, underrepresentation of patient populations in biobanks limits the generalizability of findings. The aim of this study was to assess potential age and racial/ethnic disparities in the recruitment process for an institutional breast biopsy tissue bank. Methods: Ultrasound-guided (USG) research biopsy cores were collected immediately after routine clinical biopsy from January 2019 to October 2022 at a large academic center. Study eligibility included patients (pts) aged > 18 years undergoing USG clinical breast biopsy with a radiographically evident mass ≥ 0.6 cm in the longest dimension. Eligible pts, identified by a research associate on the day of the biopsy, were invited to participate at the discretion of the radiologist performing the biopsy. Those approached either consented or declined a research biopsy. Demographic and clinical data of eligible pts were extracted from the EMR. Results: 2449 pts underwent USG breast biopsy and 1309 were deemed eligible for a research biopsy. Of the eligible population, 564 (43%) consented to the study, 322 (25%) declined, and 423 (32%) were not approached. Consented pts were younger compared to those who declined or to those not approached (median age 49, 51, and 51 years, respectively; p = .01). Comparison of study groups by age and race categories are shown in the table. Pts > 70 were less likely to be approached compared to pts < 70 (p = .01). However, The likelihood of pts being approached to consent did not differ significantly with age (p=.09 ). Of the eligible pts, 951 (73%) were White, 327 (25%) were non-White (10% Asian, 8% Black, 1% Hispanic, and 7% other race), and race was unknown for 31 (2%) pts. White and non-White pts were equally likely to be approached (p = .3). However, approached non-White pts were significantly less likely to consent compared to White pts (p =.01). Within the non-White population, Black pts were more likely to decline a research biopsy, with only 50% of approached Black pts consenting compared to 66% of White pts, 61% of Asian pts and 55% of pts of other race. Conclusions: We found disparities based on age and race/ethnicity in participation in a breast biopsy tissue biobank. Older pts were less likely to be offered participation but equally likely to consent when invited, while Black pts were equally likely to be offered participation, but less likely to consent when invited, compared to other racial subgroups. Our findings support targeted interventions to increase participation across diverse subgroups of pts.
Age, n (%) | Race, n (%) | ||||||
---|---|---|---|---|---|---|---|
< 70 | > 70 | p | White | Non-White* | Unknown | p | |
n | 1090 | 219 | 951 | 327 | 31 | ||
Approached | 753 (69) | 133 (61) | .01 | 653 (69) | 215 (66) | 18 (58) | .3 |
Not approached | 337 (31) | 86 (39) | 298 (31) | 112 (34) | 13(42) | ||
n | 753 | 133 | 653 | 215 | 18 | ||
Consented | 488 (65) | 76 (57) | .09 | 433 (66) | 119 (55) | 12 (67) | .01 |
Declined | 265 (35) | 57 (43) | 220 (34) | 96 (45) | 6 (33) |
* Asian, Black, Hispanic, Other.
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2024 ASCO Gastrointestinal Cancers Symposium
First Author: Kohei Shitara
2024 ASCO Gastrointestinal Cancers Symposium
First Author: Hendrik-Tobias Arkenau
2023 ASCO Genitourinary Cancers Symposium
First Author: Simon J. Crabb
2021 ASCO Annual Meeting
First Author: Lin Wu